Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Discover online savings accounts with top yield and solid terms. We compare rates, fees, and access so you pick the right option.
19,862 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
When headlines shift at the Fed, markets tend to move fast. This piece breaks down how Warsh becoming Fed Chair could...
Grayscale's Ethereum Staking ETF lost ground as Ether collapsed, turning a $10,000 investment into roughly $5,328 in ...
U.S. stocks fell sharply as fears of broader conflict intensified. The S&P 500 dropped about 1% in early trading, wit...
In a charged public clash, ripple accused jamie dimon of misrepresenting the CLARITY Act, igniting a broader debate o...
A fresh wave of GPU backed lending is swelling to a multi-billion market, prompting comparisons to pre-2008 mortgage ...
OpenAI's ongoing losses highlight the high-cost path of AI leadership. This article explains why two blue-chip AI sto...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
In a 5-4 ruling, the Supreme Court protected Fed independence by preserving Lisa Cook's tenure. The decision anchors ...
A sharp, fear-driven decline hit Microsoft, but a deeper look suggests the selloff may reflect sentiment more than so...
As AI stocks wobble after a rapid run, investors search for steadier footing. Here's this unstoppable vanguard could ...
AlleyCorp unveils a new $335 million fund focused on early-stage bets in healthcare and technology. The move reinforc...